MBMegha Kadam Bedekar

Megha Kadam Bedekar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Megha Kadam Bedekar has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of In vitro Antibacterial Efficacy of Terminalia catappa Leaf Extracts: A Selective Killing Approach for Disease Management in Recirculatory Aquaculture System

    by Chandru Govindan, Arun Sharma, Megha Kadam Bedekar, Thongam Ibemcha Chanu, Saloni Shivam, Haseena Shaik

    Introduction: Antibiotic resistance that has been found among pathogenic bacteria has propelled the development of alternative antimicrobial agents. This study explores the antimicrobial properties of Terminalia catappa L. (Indian almond) leaf extracts as a natural antimicrobial agent in aquaculture, focusing on their effects on pathogenic bacteria and their ability to support beneficial nitrifying bacteria in recirculating aquaculture systems (RAS). Methods: Different extracts (Methanol, Ethanol and Aqueous) of T. catappa leaves were prepared and subjected to phytochemical analysis, revealing the presence of alkaloids, flavonoids, phenols, tannins, and terpenoids. The agar well diffusion test, Minimum inhibitory concentration (MIC), and Minimum bactericidal concentration test were used to determine antibacterial efficacy against pathogenic bacteria (Aeromonas caviae, A. veronii) and nitrifying bacteria (Rhodococcus rhodochrous, Bacillus oceanisediminis). Results: The in vitro antibacterial assay results indicate that methanolic extracts at 25-250 mg/ml may inhibit pathogenic bacteria, but were less effective than other extracts against nitrifying bacteria. Electron microscopy (Field-Emission Scanning Electron Microscopy (FE-SEM) and Transmission Electron Microscopy (TEM)) was used to visualise structural damage in bacterial cells, including membrane rupture and cytoplasmic leakage, particularly in pathogenic strains. Discussion: The methanol extract of Terminalia catappa leaves was found to have strong antibacterial activity, which could be attributed to the fact that it contained higher levels of phenolics, flavonoids, and other bioactive phytochemicals than aqueous extracts. The extract was more active in inhibiting pathogenic bacteria, with a relatively weaker effect on nitrifying bacteria, suggesting a selective antibacterial action in vitro. Future research should focus on in vivo validation and dose optimisation. Conclusion: The present study has shown that, in vitro, the extracts of Terminalia catappa leaves exhibit different antibacterial activity, with high levels of inhibition against pathogenic bacterial strains, compared with the action of selected heterotrophic nitrifying bacteria. Such findings provide preliminary data on selective antibacterial activity. However, the results are limited to in vitro confirmation and require in vivo validation before proceeding to further applications in aquaculture.

  • Comparative Evaluation and Optimization of a CRISPR/Cas-Based Assay for Rapid Detection of Tilapinevirus tilapiae (TiLV) in Indian Isolates, Validated Against Conventional Nucleic acid Detection Methods

    by Kaliyamoorthy Thangadurai, Megha Kadam Bedekar, Chandraprakasham Manojkumar, Meshram Supradhnya Namdeo, Maharshi Limbola, Kezhedath Jeena, Kiran Dashrath Rasal, Kooloth Valappil Rajendran, Kundan Kumar

  • Open Access

    Development and validation of a synthetic peptide-based field deployable latex slide agglutination test for detection of Tilapia tilapinevirus

    by Meshram Supradhnya Namdeo, Megha Kadam Bedekar, Jeena Kezhedath, Kooloth Valappil Rajendran, Anisha Valsalam, Ankita Godavarikar, Pooja Vinde, Sagar Hundare, Khangembam Victoria Chanu, Dimpal Thakuria, et al.

    Tilapia significantly contributes to global food security and is an affordable protein source for most developing nations. Tilapia tilapinevirus (TiLV) poses a significant economic threat to the global tilapia industry. This study aimed to develop a rapid and accurate detection method for TiLV by synthesizing a monoclonal antibody (MAb) against it. A novel peptide, KLH-CQ, derived from the TiLV sequence, was designed considering physicochemical properties like net cationic charge, amphipathicity, helicity, and hydrophobicity. The KLH-CQ (50 µg) was used to immunize Balb/c mice with Freund's complete adjuvant. The presence of specific antibodies in the mice serum was confirmed by ELISA, which showed a high antibody titre of 2.67:0.12 (mean OD of treated Vs control sera). The mouse with the strongest immune response was used for spleen donor in hybridoma production. Epitope mapping via ELISA screening identified five positive clones (TiLV-MAb 1–5), with the most reactive clone selected for further analysis. Using Classen's method, a cutoff OD value of 1.24 ± 0.45 was determined for virus detection. The selected TiLV-MAb was then used as a probing antibody to develop a latex slide agglutination assay (TiLV-LAT) using passive adsorption method. Validation of the assay with tissue and mucus samples revealed a specificity of 88.37% and a sensitivity of 82.37% for TiLV detection. The overall accuracy of the assay was 83.51%, with positive and negative likelihood ratios of 7.06 and 0.2, respectively. The TiLV-LAT successfully detected TiLV in various tissues, showing variable sensitivity: liver (77.35%), mucus (73.53%), brain (67.92%), and kidney (62.26%). TiLV-LAT developed here has minimized the tedious steps involved in nucleic acid-based detection assays, with the recorded sensitivity and specificity; it can be used as a presumptive diagnosis for testing and point of care/farm site. Moreover, non-lethal sampling and virus testing in mucus samples would be useful for fish health monitoring.

  • Shrimp immune responses and antimicrobial peptides: an overview with emphasis on Vibrio infection

    by Naveenkumar Radhakrishnan, Akshaya Panigrahi, B. Naveen Rajeshwar, Megha Kadam Bedekar


  • CRISPR-Cas12a–based lateral flow detection of white spot syndrome virus: a dual-target approach for detection of early and latent infection

    by Chandraprakasham Manojkumar, Maharshi Limbola, Samrat Paul, Kaliyamoorthy Thangadurai, Kooloth Valappil Rajendran, Anirban Roy, Bikash Mandal, Kezhedath Jeena, Megha Kadam Bedekar

    White spot syndrome virus (WSSV; family Nimaviridae ; taxon species White spot syndrome virus ) is a major viral pathogen that poses a significant threat to the global shrimp industry, with early detection being the most effective strategy for disease control. We developed a CRISPR-Cas12a–based dual-target detection assay for WSSV, specifically targeting the VP28 gene (gene product is a major envelope protein) and WSSV366 (a latency-associated gene), optimized using Indian WSSV isolates. Our CRISPR RNAs for both targets had high efficiency, and we evaluated the assay using fluorescence-based and lateral flow strip (LFS) endpoint detection. In fluorescence assays, the Cr-WSSV assay (without recombinase polymerase amplification, RPA) detected WSSV at 3 × 10⁵ copies/μL; RPA integration significantly enhanced sensitivity, allowing detection at as low as 20 and 200 copies for VP28 and WSSV366 , respectively, with 100% specificity. We developed a CRISPR-based LFS assay with optimized FAM-biotin reporter concentrations of 100 nM and 250 nM, yielding robust and reproducible results for improved field applicability. Performance evaluation confirmed lack of cross-reactivity to other WOAH-listed shrimp pathogens, while maintaining detection limits of 20 and 200 copies of VP28 and WSSV366 . Clinical validation further demonstrated that the RPA-Cr-WSSV-LFS assay successfully detected WSSV366 even in VP28 -negative samples, underscoring the importance of detecting WSSV366 in latent infections. Our rapid, cost-effective, and highly sensitive CRISPR-Cas–based assay enhances WSSV surveillance and biosecurity in shrimp aquaculture by incorporating structural and latency-associated gene markers, making it a promising alternative to conventional molecular testing.


  • Transcriptional investigation of immune gene expression dynamics in Rohu (Labeo rohita) in response to killed Flavobacterium columnare vaccine

    by Jayalakshmi Subramaniyan Akash, Megha Kadam Bedekar, Kooloth Valappil Rajendran, Gayatri Tripathi, Anisha Valsalam, Gopal Krishna


  • Bacterial Vaccines for Fish

    by Megha K. Bedekar, Arya Singh


  • Disease Diagnosis in Aquaculture

    by K. Jeena, M. Makesh, Megha K. Bedekar, K. U. Shyam, Arun K. Dhar, K. V. Rajendran

  • First Report of Dual Infection of Hepatopancreatic Parvovirus and Enterocytozoon hepatopenaei in Wild and Farmed Macrobrachium rosenbergii

    by Amala Jiji, Nandiath Karayi Sanil, Nalini Poojary, Jeena Kezhedath, Sreedharan Krishnan, Megha K. Bedekar, K. V. Rajendran

    The freshwater prawn Macrobrachium rosenbergii is widely farmed in India, and except for Macrobrachium nodavirus (MrNV), no significant pathogens infecting this species have been reported. In this perspective, a histology‐ and PCR‐based screening of M. rosenbergii was carried out for pathogens such as hepatopancreatic parvovirus (HPV), Enterocytozoon hepatopenaei (EHP) and infectious hypodermal and haematopoietic necrosis virus (IHHNV). For this, 335 samples were collected from five locations in Kerala, Maharashtra and West Bengal, India. Fifty animals, consisting of post‐larvae, sub‐adults and adults, were subjected to histological analysis, and the majority of the post‐larvae (from Kerala) and a few sub‐adult samples (from West Bengal) showed eosinophilic to basophilic, intranuclear inclusions, typical of HPV infection. The prevalence of HPV and EHP was found to be 61.3% and 95.4%, respectively, and 56.8% of the samples displayed multiple infections. None of the samples showed the presence of IHHNV. The sequence analysis of PCR amplicons indicated 90%–93% and 100% similarity to the capsid protein gene of HPV and the spore wall protein gene of EHP, respectively. This report formed the first documentation of HPV and EHP in M. rosenbergii from India and the first report of dual infections of these pathogens in freshwater prawn.


  • Evaluating the Lethal Dose (LD50) of Ivermectin for Common Carp: Insights From an Oral Toxicity Study

    by Haseena Shaik, Arun Sharma, Megha Kadam Badekar, Saurav Kumar, Arun Konduri, Manjunath Mathew, G Chandru, Ranjit Kumar Nadella, Rajisha Ravindran, Niladri Sekhar Chatterjee, et al.

    Background: Ivermectin (IVM) is commonly used for the treatment of parasitic diseases in aquaculture and is administered either through oral or immersion methods, but it lacks regulatory approval. Objective: The aim of the present study was to determine the acute oral toxicity of IVM by estimating the 96 h median lethal dose (LD50) using mortality as endpoint, for an economically important freshwater fish, Cyprinus carpio. Methods: Medicated feed was prepared by employing different doses of IVM top-dressed onto the commercial feed pellets. A single oral dose of IVM at different doses (mg/kg b.wt.) of 0 (control-T1), 1 (T2), 2.5 (T3), 5 (T4), 10 (T5), 12 (T6), 15 (T7), 18 (T8), 21 (T9), 25 (T10), and 50 (T11) was dissolved in dimethyl sulfoxide (DMSO) and top-dressed using 0.5% w/v guar gum as a wet binder to the feed. The medicated feed was administered at 3% b.wt. to all treatment groups and cumulative mortalities were recorded over a duration of 96 h. Results: The estimated LD50 of IVM was found to be 8.91 ± 3.46 mg/kg·b.wt. Furthermore, the treatment group (T2) was administered a single oral dose of 1 mg/kg b.wt. and did not exhibit any noticeable behavioral changes compared to the control group. Similarly, LOAEL and NOEAL doses were found to be 2.5 mg/kg b.wt. and 1 mg/kg b.wt., respectively. Conclusions: This study provides valuable insights for further determining the safe dosage of IVM that can be used in aquaculture for the treatment of parasitic diseases. Highlights: The present study might be helpful for fixing the maximum residual limit (MRL) for IVM in the aquaculture sector, and the data will be helpful for prescription of the drug by regulatory authorities for treating parasitic diseases in fish.